Skin Cancer Market Size, Share, Growth Insights and Report 2024-2031 | Sanofi SA, Novartis AG, Merck & Co Inc

Skin Cancer Market Research Report By DataM Intelligence: A comprehensive analysis of current and emerging trends provides clarity on the dynamics of the Skin Cancer market. The report employs Porter's Five Forces model to assess key factors such as the influence of suppliers and customers, risks posed by different entities, competitive intensity, and the potential of emerging entrepreneurs, offering valuable insights. Additionally, the report presents research data from various companies, including their benefits, gross margins, and strategic decisions in the global market, all conveyed through tables, charts, and infographics.

Download Free Sample PDF: https://datamintelligence.com/download-sample/skin-cancer-market

What is the projected growth rate (CAGR) of the Global Skin Cancer market from 2024 to 2031, and what is the market value expected to change by 2031?

Skin Cancer Market is expected to grow at a CAGR 8% during the forecast period (2024-2031).

What is Skin Cancer Market?

Skin cancer is a disease in which abnormal skin cells grow uncontrollably, often due to DNA damage from excessive exposure to ultraviolet (UV) radiation from the sun or tanning beds. The three main types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma, with melanoma being the most aggressive and potentially life-threatening if not treated early. Early detection is crucial, as skin cancer is generally treatable when caught early, typically through surgical removal, radiation, or topical treatments. Regular skin checks and sun protection measures, such as using sunscreen and wearing protective clothing, are essential for reducing the risk of skin cancer.

Growth Driver

Growing Skin Cancer Diagnoses Expected to Drive Market Growth

The rising incidence of skin cancer, particularly in the U.S., is a significant driver for market growth in diagnosis and treatment solutions. Between 1994 and 2020, the treatment of nonmelanoma skin cancers increased by 77%, with approximately 90% of these cases linked to ultraviolet (UV) radiation exposure. According to the American Academy of Dermatology Association, around 9,500 individuals in the U.S. are diagnosed with skin cancer daily. In 2021 alone, an estimated 196,060 new cases of melanoma were expected, including both noninvasive (101,280) and invasive (106,110) cases, making invasive melanoma the fifth most commonly diagnosed cancer for men (62,260 cases) and women (43,850 cases).

Skin cancer incidence is notably higher among non-Hispanic white individuals compared to non-Hispanic Black or Asian/Pacific Islander populations. However, skin cancer in individuals with skin of color often goes undetected until later stages, making it more challenging to treat. Among African American patients, 25% of melanoma cases are diagnosed only after spreading to nearby lymph nodes, and 16% are diagnosed once the cancer has reached distant lymph nodes and other organs.

Furthermore, people with skin of color are more susceptible to skin cancer in areas that are not commonly exposed to the sun, such as the palms, soles, groin, and mouth, and they may also develop melanoma under the nails. Differences in UV exposure due to lifestyle and work patterns contribute to higher skin cancer rates in women than men before age 50, while rates are higher in men after age 50. Additionally, research shows that men aged 15-39 diagnosed with melanoma have a 55% higher mortality rate than women in the same age group.

This increasing incidence of skin cancer highlights the urgent need for improved diagnostic and treatment options, driving market growth as awareness and demand for skin cancer solutions rise.

Key Players:

Profiles of some of the major players in the global Skin Cancer market, which include: Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Abbott Laboratories.,Sanofi SA, Novartis AG, Qiagen NV and Pfizer Inc.

Industry Development:

The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical information, market data that has been confirmed by the industry, and predictions based on a sound methodology. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Skin Cancer market.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=skin-cancer-market

Market Segments:

The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviours.

By Treatment Type (Chemotherapy, Surgery, Non-Invasive Treatments, and Others)

By End User (Hospital and Clinics, Cancer Research Institutes and Others)

Regional Break out:

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/skin-cancer-market

Key Features

➧ Gain deep insights into market dynamics, trends, and opportunities to stay ahead in a competitive landscape.

➧ Track competitor's movements in real time, allowing you to swiftly adapt strategies and remain competitive.

➧ Compare your performance with industry leaders to identify gaps, strengths, and areas for improvement.

➧ Stay updated with emerging market trends, technological advancements, and customer behaviour to refine your strategy.

➧ Receive actionable insights and recommendations to drive your business toward growth and long-term success.

➧ Tailor competitive intelligence to your unique business needs, ensuring relevant and focused analysis.

➧ Evaluate supply chain efficiency and logistics strategies to optimize operations and minimize disruptions.

➧ Understand key players, stakeholders, and partnerships to navigate the competitive landscape more effectively.

➧ Identify and target specific market segments with detailed intelligence on customer preferences and behaviours.

➧ Stay informed on regulatory changes and legal requirements impacting your industry to ensure compliance and mitigate risks.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.